D.med Healthcare has completed the divestment of its subsidiary D.Med Medical Services India to Nipro Renal Care India, mastering the very specific challenges of the Indian healthcare market.
Effective from April 1, 2020, NRC India acquired D.med’s stake in DMMS India taking over the role as a leading consortium member in the Public-Private Partnership on Dialysis with the state of Telangana with D.med remaining in the consortium as QM consultant.
DMMS India started its operations in November 2017 creating a network of 40 dialysis clinics with more than 2,000 patients and made Telangana the first Indian state to offer public single-use dialysis lifting the treatment of kidney failure to an unprecedented level of quality.
“We wish Nipro Renal Care India best of luck with the further development of this project. Our sincere gratitude goes to the Government and people of Telangana for the trust they have put in us, and to each one of our Indian team for having brought us where DMMS India is today”, said Sven-Axel Krentorz, CEO of D.med Healthcare. “By combining the expertise of NRC India as a group company of Nipro Corp, one of the leading global manufacturers of dialysis products, with the strong fundament we have created, this project will continue to serve the needs of patients excellently.“
According to a statement of Milind Pappu, President of NRC India, NIPRO is pleased to take over the stake of D.med Healthcare in DMMS India adding to NIPRO’s already existing local footprint of a dialysis products manufacturing facility and sales & service operations in 18 states across India and enabling NIPRO to provide high-quality dialysis services in Telangana in line with international standards.
For further information on NIPRO’s Indian operations, please refer to www.niproindia.com.